J Gastroenterol Hepatol. 2007;22(10):1605-1608. A final diagnosis was established in 22 patients in the mosapride group (73.3%) compared with 15 patients in the control group (50%, P = 0.110 ...

Adult: Oral- The recommended dose is 5mg, 3 times/day.

No adverse events associated with mosapride including prolonged QT syndrome were observed during the study or follow-up. A total of 5 patients (including 1 abdominal pain, 2 dry mouth, 2 insomnia ...

Review the side-effects of Mosapride as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...